Current status and challenges of stem cell-based therapy for the treating of glioblastoma multiforme Stem cell-based therapy treating glioblastoma multiforme

Glioblastoma (GB) is one of the most malignant types of central nervous system tumours, classified as grade IV by the World Health Organization. Despite the therapeutic advances, the prognosis is ominous, with a median survival of about 12–15 months post diagnosis. Although therapeutic options avail...

Full description

Bibliographic Details

Main Authors:	Banafshe Abadi, Meysam Ahmadi-Zeidabadi, Luciana Dini, Cristian Vergallo
Format:	Artigo
Language:	Inglês
Published:	Wolters Kluwer Medknow Publications 2021-01-01
Series:	Hematology/Oncology and Stem Cell Therapy
Subjects:	anticancer stem cell-based therapy glioblastoma gliomas stem cells
Online Access:	https://journals.lww.com/10.1016/j.hemonc.2020.08.001
Tags:	Add Tag No Tags, Be the first to tag this record!